Abeona Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview

Abeona Therapeutics

08/08/2025 19:01

Abeona Therapeutics Inc ABEO.OQ ABEO.O is expected to  show no change in quarterly revenue when it reports  results on August 11 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Abeona Therapeutics Inc is for a loss of 39 cents per share.

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Abeona Therapeutics Inc is $20.00, about 68.7% above its last closing price of $6.27

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATEÂŪ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.36
-0.36
-0.24
Beat
33.9
Dec. 31 2025
-0.35
-0.35
-0.14
Beat
60.5
Sep. 30 2024
-0.41
-0.40
-0.63
Missed
-55.9​
Jun. 30 2024
-0.39
-0.36
0.19
Beat
152.2
​​Mar. 31 2024
-0.51
-0.51
-1.16
Missed
-126
Dec. 31 2023
-0.47
-0.77
Missed
-63.8​
Sep. 30 2023
-0.53
-0.53
-0.48
Beat
8.9
Jun. 30 2023
-0.71
-0.68
-0.92
Missed
-35.3

This summary was machine generated August 8 at 18:01 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)